NCT01733823View on ClinicalTrials.gov

DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
HNSCC,Larynx, Pharynx and Oral Cavity
Interventions
RADIATION

76 Gy/ 56 fx/ 10/W with cisplatin 40 mg/m2/W and nimorazole

Trial Locations (4)

2730

Herlev, Herlev

5000

Odense, Odense

8000

Aarhus, Aarhus

9100

Aalborg, Aalborg

All Listed Sponsors
lead

Danish Head and Neck Cancer Group

NETWORK

NCT01733823 - DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole | Biotech Hunter | Biotech Hunter